Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CDXCNYSE:HEXONASDAQ:SNDLNYSE:USNA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCDXCChromaDex$6.16$2.41▼$9.18$611.50M2.21813,055 shs554,788 shsHEXOHEXO$0.71+2.5%$0.87$0.66▼$3.84$31.24M1.35880,508 shs305,500 shsSNDLSNDL$1.28+2.0%$1.30$1.15▼$2.40$333.73M3.41.95 million shs1.10 million shsUSNAUSANA Health Sciences$32.77+1.0%$29.95$23.10▼$48.85$610.28M0.64139,916 shs55,638 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCDXCChromaDex0.00%0.00%0.00%0.00%+209.65%HEXOHEXO0.00%0.00%0.00%0.00%0.00%SNDLSNDL0.00%+3.66%-1.16%-6.93%-34.95%USNAUSANA Health Sciences0.00%+5.04%+10.08%+28.52%-27.13%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCDXCChromaDex3.2269 of 5 stars3.50.00.04.00.00.01.9HEXOHEXON/AN/AN/AN/AN/AN/AN/AN/ASNDLSNDL3.6718 of 5 stars3.55.00.00.02.00.01.3USNAUSANA Health Sciences3.4383 of 5 stars1.02.00.03.32.01.73.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCDXCChromaDex 3.00Buy$9.03∞ UpsideHEXOHEXO 0.00N/AN/AN/ASNDLSNDL 3.00Buy$3.63184.31% UpsideUSNAUSANA Health Sciences 2.00Hold$36.009.86% UpsideCurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCDXCChromaDex$99.60M0.00N/AN/A$0.38 per share0.00HEXOHEXO$146.20M0.21N/AN/A$2.44 per share0.29SNDLSNDL$671.81M0.50N/AN/A$3.15 per share0.40USNAUSANA Health Sciences$854.50M0.71$3.78 per share8.68$27.92 per share1.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCDXCChromaDex-$4.94M$0.10787.290.00N/A1.62%4.85%2.70%N/AHEXOHEXO-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/ASNDLSNDL-$69.18M-$0.29N/AN/AN/A-11.48%-9.02%-7.60%7/30/2025 (Estimated)USNAUSANA Health Sciences$42.03M$1.8218.0111.341.053.98%8.94%6.74%7/22/2025 (Estimated)Latest USNA, SNDL, HEXO, and CDXC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2025Q2 2025USNAUSANA Health Sciences$0.54N/AN/AN/A$225.20 millionN/A5/1/2025Q1 2025SNDLSNDL-$0.06-$0.04+$0.02-$0.04$214.60 million$142.38 million4/22/2025Q1 2025USNAUSANA Health Sciences$0.70$0.73+$0.03$0.49$243.08 million$249.54 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCDXCChromaDexN/AN/AN/AN/AN/AHEXOHEXON/AN/AN/AN/AN/ASNDLSNDLN/AN/AN/AN/AN/AUSNAUSANA Health SciencesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCDXCChromaDexN/A2.952.35HEXOHEXO0.010.410.24SNDLSNDL0.104.623.12USNAUSANA Health SciencesN/A2.051.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCDXCChromaDex15.41%HEXOHEXO7.78%SNDLSNDLN/AUSNAUSANA Health Sciences54.25%Insider OwnershipCompanyInsider OwnershipCDXCChromaDex9.64%HEXOHEXO4.69%SNDLSNDLN/AUSNAUSANA Health Sciences0.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCDXCChromaDex12077.75 million69.02 millionOptionableHEXOHEXO1,27744.00 million41.93 millionOptionableSNDLSNDL2,516262.78 millionN/AOptionableUSNAUSANA Health Sciences1,90018.62 million18.51 millionOptionableUSNA, SNDL, HEXO, and CDXC HeadlinesRecent News About These CompaniesUSANA Health Sciences: Premium Formulation, Discounted ValuationJuly 4 at 12:34 PM | seekingalpha.comUSANA Health Sciences: Premium Formulation, Discounted ValuationJuly 4 at 12:03 PM | seekingalpha.comUSANA Schedules Second Quarter 2025 Earnings Release and Conference CallJuly 2 at 4:15 PM | businesswire.comUSANA Executive Chairman Kevin Guest Invites All to Discover Freedom in JulyJuly 2 at 7:37 AM | prnewswire.comUSANA Health Secures New Credit Agreement with BankJuly 1, 2025 | tipranks.comUSANA Announces the Elevation of Its OpportunityJuly 1, 2025 | prnewswire.comUSANA Health Sciences (NYSE:USNA) Stock Passes Above Two Hundred Day Moving Average - Time to Sell?July 1, 2025 | marketbeat.comGAMMA Investing LLC Has $225,000 Holdings in USANA Health Sciences, Inc. (NYSE:USNA)June 22, 2025 | marketbeat.comRhumbline Advisers Has $979,000 Stake in USANA Health Sciences, Inc. (NYSE:USNA)June 20, 2025 | marketbeat.comUSNA vs. STVN: Which Stock Is the Better Value Option?June 18, 2025 | zacks.comUSANA Health (USNA) Upgraded to Buy: Here's What You Should KnowJune 17, 2025 | zacks.comIs USANA Health Sciences (USNA) Stock Undervalued Right Now?June 17, 2025 | zacks.com5 Low Price-to-Book Value Stocks That You Can Buy in JuneJune 17, 2025 | zacks.comUSANA Health Sciences, Inc. (NYSE:USNA) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?June 17, 2025 | finance.yahoo.comUSANA CEO Elected to Board of Direct Selling AssociationJune 17, 2025 | prnewswire.comUSANA Takes Home Five Best of State Awards, Including the Coveted Best of State StatueJune 12, 2025 | prnewswire.comUSANA Health Sciences, Inc. (NYSE:USNA) Director Sells $14,830.00 in StockJune 10, 2025 | marketbeat.comMillennium Management LLC Makes New Investment in USANA Health Sciences, Inc. (NYSE:USNA)June 8, 2025 | marketbeat.comReflecting On Personal Care Stocks’ Q1 Earnings: USANA (NYSE:USNA)June 4, 2025 | msn.comUSANA Executive Chairman Kevin Guest Celebrates National Outdoors Month with a Call to ...June 2, 2025 | gurufocus.comUSANA Executive Chairman Kevin Guest Celebrates National Outdoors Month with a Call to Reconnect with NatureJune 2, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUSNA, SNDL, HEXO, and CDXC Company DescriptionsChromaDex NASDAQ:CDXCChromaDex Corporation operates as a bioscience company focusing on developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and Immulina, a spirulina extract with predominant active compounds of Braun-type lipoproteins for supporting human immune function. In addition, it offers phytochemical reference standards, and other research and development services. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation was founded in 1999 and is headquartered in Los Angeles, California.HEXO NYSE:HEXOHEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.SNDL NASDAQ:SNDL$1.27 +0.03 (+2.00%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$1.27 0.00 (-0.39%) As of 07/3/2025 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.USANA Health Sciences NYSE:USNA$32.77 +0.32 (+0.99%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$32.74 -0.03 (-0.08%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
